Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Clinical trial NCT07082842 · RECRUITING

Trial details

NCT number: NCT07082842
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis (IPF)

Start date: 2025-10-27
Primary completion: 2031-01-15
Enrollment: 472

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.